Bottom line
ERHSX vs FHLC: the short answer
ERHSX (Eaton Vance Worldwide Health Sciences Fund) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
But FHLC is far broader, holding 337 positions to 42 for ERHSX, so beyond the top names it adds exposure ERHSX doesn't have.
FHLC is cheaper at 0.084% vs 1.43% — a difference of $135 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +6.2% for ERHSX (reporting dates differ).
Updated Nov 19, 2026
ERHSX vs FHLC side by side
| ERHSX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Morgan Stanley | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.43% | 0.084% |
| Annual cost per $10k | $143 | $8.4 |
| 10-yr cost on $10k (prospectus) | $1,744 | $108 |
| Max front load | 0% | None |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +3.2% | +2.6% |
| 5-yr return (annualized) | +6.2% | +7.2% |
| 10-yr return (annualized) | +6.7% | +8.8% |
| Best quarter | — | +16.4% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $757.9M | $3.3B |
| Number of holdings | 42 | 337 |
| Portfolio turnover | 3% | 3% |
| Returns as of | Dec 31, 2024 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of ERHSX's top 25 holdings also appear in FHLC's top 25.
| Holding | ERHSX | FHLC |
|---|---|---|
| Eli Lilly & Co | 12.47% | 13.35% |
| AbbVie Inc | 6.46% | 6.42% |
| Johnson & Johnson | 6.45% | 8.93% |
| UnitedHealth Group Inc | 5.49% | 5.44% |
| Merck & Co Inc | 5.08% | 4.66% |
| Bristol-Myers Squibb Co | 4.25% | 1.93% |
| Vertex Pharmaceuticals Inc | 3.38% | 1.76% |
| Gilead Sciences Inc | 3.34% | 2.34% |
| Thermo Fisher Scientific Inc | 2.79% | 3.09% |
| Intuitive Surgical Inc | 2.72% | 1.82% |
| Stryker Corp | 2.21% | 1.62% |
| Boston Scientific Corp | 2.18% | 1.00% |
| Medtronic PLC | 1.80% | 1.59% |
| Abbott Laboratories | 1.65% | 2.66% |
Source: SEC Form N-PORT
ERHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between ERHSX and FHLC?
Which is cheaper, ERHSX or FHLC?
Should I own both ERHSX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.